English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

There have been growing concerns that antimicrobial resistance (AMR) poses major threats to global public health. In Europe alone, it is responsible for about 25,000 hospital deaths caused by selected multidrug resistant infections, leading to an economic burden of 1.5 billion Euros per year [1]. Antibiotic use appears to be an important factor contributing to increase in resistance at the population and individual level [2]. AMR develops rapidly through misuse or over use of antibiotics, which affects patients, families, carers and the society as a whole. Over 80% of all antibiotic prescribed in the United Kingdom (UK) are in primary care [3], and about a half of these are regarded as unnecessary. Respiratory Tract Infections (RTIs) account for the highest percentage (60%) of all antibiotic prescribed in the primary care in the UK [4]. This clearly imposes a huge burden on clinicians and other healthcare services used to manage common infections, e.g. RTIs, Urinary Tract Infections (UTIs), etc.

Managing Common Infections in Primary Care: Economic Evaluation of Interventions Targeting Antibiotic Prescribing